ファーマコビジランスと医薬品安全性ソフトウェアの世界市場レポート 2025年

ファーマコビジランスと医薬品安全性ソフトウェア市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR12.9％で41億5,000万米ドルに成長します。予測期間の成長は、副作用発生率の上昇とファーマコビジランスの世界化、医薬品安全規制の複雑化、新薬や治療法の開発増加、医薬品副作用（ADR）発生率の上昇、医薬品副作用件数の増加に起因すると考えられます。予測期間における主な動向としては、自動化とAIの統合、クラウドベースのソリューション、技術革新、技術の進歩、ヘルスケアのデジタル化の進展などが挙げられます。

個別化医療に対する需要の高まりが、今後数年間のファーマコビジランスと医薬品安全性ソフトウェア市場の成長を促進すると予測されます。精密医療としても知られる個別化医療は、患者一人ひとりの特性に基づいて医療上の意思決定や治療をカスタマイズするヘルスケアアプローチです。この需要の高まりは、治療成果の向上、予防と早期発見の重視、費用対効果の改善など、いくつかの要因に影響されています。ファーマコビジランスと医薬品安全性ソフトウェアは、個別化医療の成功に極めて重要な役割を果たします。薬理遺伝学、リアルタイムのデータ解析、市販後調査、個別化された薬剤情報などを統合することで、これらのツールは個別化治療の安全性と有効性を高めると同時に、強固なリスク管理戦略をサポートし、倫理的配慮に対処します。例えば、2024年2月、米国の非営利団体である個別化医療連合（Personalized Medicine Coalition）は、2023年にFDAが希少疾患患者向けに16の新規個別化治療を承認したと報告しました。その結果、個別化医療に対する需要の高まりがファーマコビジランスと医薬品安全性ソフトウェア市場の成長を牽引しています。

ファーマコビジランスと医薬品安全性ソフトウェア市場の主要企業は、クラウドベースのデータレイクプラットフォームなどの革新的な技術を開発し、患者の安全性を向上させ、有害事象をより効果的に監視し、臨床試験や医療機器の市販後調査における規制遵守を強化しています。クラウドベースのデータレイク・プラットフォームは、組織が膨大な量の構造化データおよび非構造化データを保存、管理、分析できるスケーラブルな集中ストレージシステムとして機能します。リアルタイムのデータアクセスを提供し、高度な分析やAI/MLワークロードをサポートします。例えば、米国のバイオテクノロジー企業であるサーモフィッシャーサイエンティフィック社は、2023年12月、臨床研究登録内のファーマコビジランスプロセスを強化するために設計された独自のクラウドベースのデータレイクプラットフォームであるCorEvidenceを発表しました。このプラットフォームは、特に承認後の安全性試験における症例処理と安全性データ管理を最適化することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ファーマコビジランスと医薬品安全性ソフトウェア PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のファーマコビジランスと医薬品安全性ソフトウェア市場：成長率分析
• 世界のファーマコビジランスと医薬品安全性ソフトウェア市場の実績：規模と成長, 2019-2024
• 世界のファーマコビジランスと医薬品安全性ソフトウェア市場の予測：規模と成長, 2024-2029, 2034F
• 世界ファーマコビジランスと医薬品安全性ソフトウェア総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のファーマコビジランスと医薬品安全性ソフトウェア市場：ソフトウェア種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 有害事象報告ソフトウェア
• 医薬品安全性監査ソフトウェア
• 問題追跡ソフトウェア
• 完全に統合されたソフトウェア
• 世界のファーマコビジランスと医薬品安全性ソフトウェア市場配送方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンプレミス
• クラウドベース
• 世界のファーマコビジランスと医薬品安全性ソフトウェア市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー企業
• 契約調査機関
• ビジネスプロセスアウトソーシング企業
• その他のエンドユーザー
• 世界のファーマコビジランスと医薬品安全性ソフトウェア市場有害事象報告ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自発的報告システム
• EHR統合ソリューション
• モバイルレポートアプリケーション
• 世界のファーマコビジランスと医薬品安全性ソフトウェア市場医薬品安全性監査ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 監査管理ソリューション
• コンプライアンス追跡ツール
• レポートおよび分析モジュール
• 世界のファーマコビジランスと医薬品安全性ソフトウェア市場問題追跡ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• インシデント報告システム
• ワークフロー管理ツール
• コラボレーションプラットフォーム
• 世界のファーマコビジランスと医薬品安全性ソフトウェア市場、タイプ別完全統合ソフトウェアのサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品安全性監視プラットフォーム
• 規制コンプライアンスシステム
• データ分析と可視化ツール

第7章 地域別・国別分析

• 世界のファーマコビジランスと医薬品安全性ソフトウェア市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のファーマコビジランスと医薬品安全性ソフトウェア市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ファーマコビジランスと医薬品安全性ソフトウェア市場：競合情勢
• ファーマコビジランスと医薬品安全性ソフトウェア市場：企業プロファイル
  • Accenture plc Overview, Products and Services, Strategy and Financial Analysis
  • International Business Machines Corporation（IBM）Overview, Products and Services, Strategy and Financial Analysis
  • Deloitte Touche Tohmatsu Limited Overview, Products and Services, Strategy and Financial Analysis
  • Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Capgemini SE Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Cognizant Technology Solutions
• IQVIA
• Wipro Limited
• Genpact
• Parexel Academy
• PharmaLex
• Indegene Limited
• RXLogix
• Sarjen Systems Pvt Ltd
• Anju Software Inc.
• Ennov Group
• EXTEDO GmbH
• ArisGlobal
• AB Cube
• Clinevo Technologies

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ファーマコビジランスと医薬品安全性ソフトウェア市場2029：新たな機会を提供する国
• ファーマコビジランスと医薬品安全性ソフトウェア市場2029：新たな機会を提供するセグメント
• ファーマコビジランスと医薬品安全性ソフトウェア市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharmacovigilance and drug safety software comprises a suite of digital tools aimed at monitoring, analyzing, and reporting adverse drug reactions (ADRs) and other safety-related information linked to pharmaceuticals and medical products. This software is essential for ensuring patient safety and maintaining regulatory compliance throughout a drug's lifecycle, from development to post-marketing surveillance.

The primary types of pharmacovigilance and drug safety software include adverse event reporting software, drug safety audit software, issue tracking software, and fully integrated software solutions. Adverse event reporting software specifically focuses on tracking, documenting, and managing adverse events associated with pharmaceutical products or medical devices. These solutions are available in both on-premise and cloud-based delivery modes and are utilized by a variety of end users, including pharmaceutical and biotechnology companies, contract research organizations, business process outsourcing firms, and others.

The pharmacovigilance and drug safety software market research report is one of a series of new reports from The Business Research Company that provides pharmacovigilance and drug safety software market statistics, including pharmacovigilance and drug safety software industry global market size, regional shares, competitors with a pharmacovigilance and drug safety software market share, detailed pharmacovigilance and drug safety software market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacovigilance and drug safety software industry. This pharmacovigilance and drug safety software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmacovigilance and drug safety software market size has grown rapidly in recent years. It will grow from $2.26 billion in 2024 to $2.55 billion in 2025 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to increasing the demand for pharmacovigilance and drug safety software.

The pharmacovigilance and drug safety software market size is expected to see rapid growth in the next few years. It will grow to $4.15 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to rising adverse drug reaction incidences and the globalization of pharmacovigilance, growing incidence of adverse drug reactions, increased complexity in drug safety regulations, increase in the development of new drugs and therapies, increasing incidence of adverse drug reactions (ADRs), rising number of adverse drug reactions. Major trends in the forecast period include automation and AI integration, cloud-based solutions, technological innovation, advancement in technologies, and increasing healthcare digitalization.

The increasing demand for personalized medicine is projected to drive growth in the pharmacovigilance and drug safety software market in the coming years. Also known as precision medicine, personalized medicine is a healthcare approach that customizes medical decisions and treatments based on the unique characteristics of each patient. This growing demand is influenced by several factors, including enhanced treatment outcomes, a focus on prevention and early detection, and improved cost-effectiveness. Pharmacovigilance and drug safety software play a crucial role in the success of personalized medicine. By integrating pharmacogenetics, real-time data analysis, post-marketing surveillance, and personalized medication information, these tools enhance the safety and efficacy of individualized treatments while supporting robust risk management strategies and addressing ethical considerations. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a significant increase from six in 2022. Consequently, the rising demand for personalized medicine is driving growth in the pharmacovigilance and drug safety software market.

Leading companies in the pharmacovigilance and drug safety software market are developing innovative technologies, such as cloud-based data lake platforms, to improve patient safety, monitor adverse events more effectively, and enhance regulatory compliance in clinical trials and post-market surveillance of medical devices. A cloud-based data lake platform serves as a scalable, centralized storage system that allows organizations to store, manage, and analyze vast amounts of structured and unstructured data. It provides real-time data access and supports advanced analytics as well as AI/ML workloads. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology firm, launched CorEvidence, a proprietary cloud-based data lake platform designed to enhance pharmacovigilance processes within clinical research registries. This platform aims to optimize case processing and safety data management, particularly for post-authorization safety studies.

In April 2024, Qinecsa, a UK-based company, acquired Insife ApS for an undisclosed amount. This strategic acquisition is intended to strengthen Qinecsa's offerings in end-to-end pharmacovigilance technology solutions, aligning with its ambition to become a leading provider in the digital pharmacovigilance sector. Insife ApS is a Denmark-based company specializing in pharmacovigilance software.

Major companies operating in the pharmacovigilance and drug safety software market are Accenture plc, International Business Machines Corporation, Deloitte Touche Tohmatsu Limited, Oracle Corporation, Capgemini SE, Cognizant Technology Solutions, IQVIA, Wipro Limited, Genepact, Parexel Academy, PharmaLex, Indegene Limited, RXLogix, Sarjen Systems Pvt Ltd, Anju Software Inc., Ennov Group, EXTEDO GmbH, ArisGlobal, AB Cube, Clinevo Technologies

North America was the largest region in the pharmacovigilance and drug safety software market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacovigilance and drug safety software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmacovigilance and drug safety software market includes revenues earned by entities by signal detection and management tools, risk assessment, and management software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacovigilance And Drug Safety Software Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmacovigilance and drug safety software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacovigilance and drug safety software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmacovigilance and drug safety software market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Software Type: Adverse Event Reporting Software; Drug Safety Audits Software; Issue Tracking Software; Fully Integrated Software
• 2) By Delivery Mode: On-premise; Cloud-based
• 3) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Business Process Outsourcing Firms; Other End Users
• Subsegments:
• 1) By Adverse Event Reporting Software: Spontaneous Reporting Systems; EHR Integration Solutions; Mobile Reporting Applications
• 2) By Drug Safety Audits Software: Audit Management Solutions; Compliance Tracking Tools; Reporting And Analytics Modules
• 3) By Issue Tracking Software: Incident Reporting Systems; Workflow Management Tools; Collaboration Platforms
• 4) By Fully Integrated Software: Pharmacovigilance Platforms; Regulatory Compliance Systems; Data Analytics And Visualization Tools
• Companies Mentioned: Accenture plc; International Business Machines Corporation; Deloitte Touche Tohmatsu Limited; Oracle Corporation; Capgemini SE
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmacovigilance And Drug Safety Software Market Characteristics

3. Pharmacovigilance And Drug Safety Software Market Trends And Strategies

4. Pharmacovigilance And Drug Safety Software Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharmacovigilance And Drug Safety Software Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmacovigilance And Drug Safety Software PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmacovigilance And Drug Safety Software Market Growth Rate Analysis
• 5.4. Global Pharmacovigilance And Drug Safety Software Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmacovigilance And Drug Safety Software Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmacovigilance And Drug Safety Software Total Addressable Market (TAM)

6. Pharmacovigilance And Drug Safety Software Market Segmentation

• 6.1. Global Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adverse Event Reporting Software
• Drug Safety Audits Software
• Issue Tracking Software
• Fully Integrated Software
• 6.2. Global Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• On-premise
• Cloud-based
• 6.3. Global Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Contract Research Organizations
• Business Process Outsourcing Firms
• Other End Users
• 6.4. Global Pharmacovigilance And Drug Safety Software Market, Sub-Segmentation Of Adverse Event Reporting Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spontaneous Reporting Systems
• EHR Integration Solutions
• Mobile Reporting Applications
• 6.5. Global Pharmacovigilance And Drug Safety Software Market, Sub-Segmentation Of Drug Safety Audits Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Audit Management Solutions
• Compliance Tracking Tools
• Reporting And Analytics Modules
• 6.6. Global Pharmacovigilance And Drug Safety Software Market, Sub-Segmentation Of Issue Tracking Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Incident Reporting Systems
• Workflow Management Tools
• Collaboration Platforms
• 6.7. Global Pharmacovigilance And Drug Safety Software Market, Sub-Segmentation Of Fully Integrated Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacovigilance Platforms
• Regulatory Compliance Systems
• Data Analytics And Visualization Tools

7. Pharmacovigilance And Drug Safety Software Market Regional And Country Analysis

• 7.1. Global Pharmacovigilance And Drug Safety Software Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmacovigilance And Drug Safety Software Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmacovigilance And Drug Safety Software Market

• 8.1. Asia-Pacific Pharmacovigilance And Drug Safety Software Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmacovigilance And Drug Safety Software Market

• 9.1. China Pharmacovigilance And Drug Safety Software Market Overview
• 9.2. China Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmacovigilance And Drug Safety Software Market

• 10.1. India Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmacovigilance And Drug Safety Software Market

• 11.1. Japan Pharmacovigilance And Drug Safety Software Market Overview
• 11.2. Japan Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmacovigilance And Drug Safety Software Market

• 12.1. Australia Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmacovigilance And Drug Safety Software Market

• 13.1. Indonesia Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmacovigilance And Drug Safety Software Market

• 14.1. South Korea Pharmacovigilance And Drug Safety Software Market Overview
• 14.2. South Korea Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmacovigilance And Drug Safety Software Market

• 15.1. Western Europe Pharmacovigilance And Drug Safety Software Market Overview
• 15.2. Western Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmacovigilance And Drug Safety Software Market

• 16.1. UK Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmacovigilance And Drug Safety Software Market

• 17.1. Germany Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmacovigilance And Drug Safety Software Market

• 18.1. France Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmacovigilance And Drug Safety Software Market

• 19.1. Italy Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmacovigilance And Drug Safety Software Market

• 20.1. Spain Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmacovigilance And Drug Safety Software Market

• 21.1. Eastern Europe Pharmacovigilance And Drug Safety Software Market Overview
• 21.2. Eastern Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmacovigilance And Drug Safety Software Market

• 22.1. Russia Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmacovigilance And Drug Safety Software Market

• 23.1. North America Pharmacovigilance And Drug Safety Software Market Overview
• 23.2. North America Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmacovigilance And Drug Safety Software Market

• 24.1. USA Pharmacovigilance And Drug Safety Software Market Overview
• 24.2. USA Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmacovigilance And Drug Safety Software Market

• 25.1. Canada Pharmacovigilance And Drug Safety Software Market Overview
• 25.2. Canada Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmacovigilance And Drug Safety Software Market

• 26.1. South America Pharmacovigilance And Drug Safety Software Market Overview
• 26.2. South America Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmacovigilance And Drug Safety Software Market

• 27.1. Brazil Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmacovigilance And Drug Safety Software Market

• 28.1. Middle East Pharmacovigilance And Drug Safety Software Market Overview
• 28.2. Middle East Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmacovigilance And Drug Safety Software Market

• 29.1. Africa Pharmacovigilance And Drug Safety Software Market Overview
• 29.2. Africa Pharmacovigilance And Drug Safety Software Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmacovigilance And Drug Safety Software Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmacovigilance And Drug Safety Software Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmacovigilance And Drug Safety Software Market Competitive Landscape And Company Profiles

• 30.1. Pharmacovigilance And Drug Safety Software Market Competitive Landscape
• 30.2. Pharmacovigilance And Drug Safety Software Market Company Profiles
  • 30.2.1. Accenture plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Deloitte Touche Tohmatsu Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Capgemini SE Overview, Products and Services, Strategy and Financial Analysis

31. Pharmacovigilance And Drug Safety Software Market Other Major And Innovative Companies

• 31.1. Cognizant Technology Solutions
• 31.2. IQVIA
• 31.3. Wipro Limited
• 31.4. Genpact
• 31.5. Parexel Academy
• 31.6. PharmaLex
• 31.7. Indegene Limited
• 31.8. RXLogix
• 31.9. Sarjen Systems Pvt Ltd
• 31.10. Anju Software Inc.
• 31.11. Ennov Group
• 31.12. EXTEDO GmbH
• 31.13. ArisGlobal
• 31.14. AB Cube
• 31.15. Clinevo Technologies

32. Global Pharmacovigilance And Drug Safety Software Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmacovigilance And Drug Safety Software Market

34. Recent Developments In The Pharmacovigilance And Drug Safety Software Market

35. Pharmacovigilance And Drug Safety Software Market High Potential Countries, Segments and Strategies

• 35.1 Pharmacovigilance And Drug Safety Software Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmacovigilance And Drug Safety Software Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmacovigilance And Drug Safety Software Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer